These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 16087912
1. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Rupprecht TA, Pfister HW, Angele B, Kastenbauer S, Wilske B, Koedel U. Neurology; 2005 Aug 09; 65(3):448-50. PubMed ID: 16087912 [Abstract] [Full Text] [Related]
2. Sublime diagnosis of Lyme neuroborreliosis. Segal BM, Logigian EL. Neurology; 2005 Aug 09; 65(3):351-2. PubMed ID: 16087895 [No Abstract] [Full Text] [Related]
4. [New biomarker discovered. Will the diagnosis of neuroborreliosis soon be easier (interview by Maria Weiss)?]. Rupprecht T. MMW Fortschr Med; 2009 Apr 30; 151(18):8. PubMed ID: 19769063 [No Abstract] [Full Text] [Related]
5. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis. Tjernberg I, Henningsson AJ, Eliasson I, Forsberg P, Ernerudh J. J Infect; 2011 Feb 30; 62(2):149-58. PubMed ID: 21087629 [Abstract] [Full Text] [Related]
7. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA. Neurology; 2011 Mar 22; 76(12):1051-8. PubMed ID: 21422457 [Abstract] [Full Text] [Related]
8. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis. Grygorczuk S, Zajkowska J, Swierzbińska R, Pancewicz S, Kondrusik M, Hermanowska-Szpakowicz T. Rocz Akad Med Bialymst; 2005 Mar 22; 50():173-8. PubMed ID: 16358960 [Abstract] [Full Text] [Related]
10. [Diagnostic difficulties in neuroborreliosis in children]. Talarek E, Duszczyk E, Zarnowska H. Przegl Epidemiol; 2007 Mar 22; 61(1):73-8. PubMed ID: 17702442 [Abstract] [Full Text] [Related]
13. CXCL13 chemokine in pediatric and adult neuroborreliosis. Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E. Acta Neurol Scand; 2011 Nov 22; 124(5):321-8. PubMed ID: 21320077 [Abstract] [Full Text] [Related]
16. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study. Gyllemark P, Forsberg P, Ernerudh J, Henningsson AJ. J Neuroinflammation; 2017 Feb 01; 14(1):27. PubMed ID: 28148307 [Abstract] [Full Text] [Related]
17. CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients. Wagner JN, Weis S, Kubasta C, Panholzer J, von Oertzen TJ. J Neurol; 2018 Jan 01; 265(1):74-81. PubMed ID: 29134272 [Abstract] [Full Text] [Related]
18. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children. Barstad B, Tveitnes D, Noraas S, Selvik Ask I, Saeed M, Bosse F, Vigemyr G, Huber I, Øymar K. Pediatr Infect Dis J; 2017 Dec 01; 36(12):e286-e292. PubMed ID: 28661964 [Abstract] [Full Text] [Related]